
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 28, 2022, titled "Glenmark Pharmaceuticals receives ANDA approval for Metronidazole Vaginal Gel, 0.75%".
Filed with NSE · · 3 pages · English

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 28, 2022, titled "Glenmark Pharmaceuticals receives ANDA approval for Metronidazole Vaginal Gel, 0.75%".
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals